MNKD
Price
$3.81
Change
+$0.06 (+1.60%)
Updated
Jun 18 closing price
Capitalization
1.14B
48 days until earnings call
UNCY
Price
$0.67
Change
-$0.02 (-2.90%)
Updated
Jun 18 closing price
Capitalization
805.2M
60 days until earnings call
Interact to see
Advertisement

MNKD vs UNCY

Header iconMNKD vs UNCY Comparison
Open Charts MNKD vs UNCYBanner chart's image
MannKind
Price$3.81
Change+$0.06 (+1.60%)
Volume$3.42M
Capitalization1.14B
Unicycive Therapeutics
Price$0.67
Change-$0.02 (-2.90%)
Volume$7.58M
Capitalization805.2M
MNKD vs UNCY Comparison Chart in %
Loading...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MNKD vs. UNCY commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNKD is a Hold and UNCY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2025
Stock price -- (MNKD: $3.81 vs. UNCY: $0.67)
Brand notoriety: MNKD and UNCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNKD: 173% vs. UNCY: 208%
Market capitalization -- MNKD: $1.14B vs. UNCY: $805.2M
MNKD [@Biotechnology] is valued at $1.14B. UNCY’s [@Biotechnology] market capitalization is $805.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $335.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNKD’s FA Score shows that 0 FA rating(s) are green whileUNCY’s FA Score has 0 green FA rating(s).

  • MNKD’s FA Score: 0 green, 5 red.
  • UNCY’s FA Score: 0 green, 5 red.
According to our system of comparison, MNKD is a better buy in the long-term than UNCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNKD’s TA Score shows that 4 TA indicator(s) are bullish while UNCY’s TA Score has 4 bullish TA indicator(s).

  • MNKD’s TA Score: 4 bullish, 4 bearish.
  • UNCY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MNKD is a better buy in the short-term than UNCY.

Price Growth

MNKD (@Biotechnology) experienced а -1.80% price change this week, while UNCY (@Biotechnology) price change was +5.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.32%. For the same industry, the average monthly price growth was +13.75%, and the average quarterly price growth was +8.90%.

Reported Earning Dates

MNKD is expected to report earnings on Aug 06, 2025.

UNCY is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+7.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNKD($1.14B) has a higher market cap than UNCY($805M). UNCY YTD gains are higher at: -15.953 vs. MNKD (-40.747). MNKD has higher annual earnings (EBITDA): 82.6M vs. UNCY (-14.85M). MNKD has more cash in the bank: 182M vs. UNCY (19.8M). UNCY has less debt than MNKD: UNCY (694K) vs MNKD (47.2M). MNKD has higher revenues than UNCY: MNKD (298M) vs UNCY (0).
MNKDUNCYMNKD / UNCY
Capitalization1.14B805M142%
EBITDA82.6M-14.85M-556%
Gain YTD-40.747-15.953255%
P/E Ratio38.10N/A-
Revenue298M0-
Total Cash182M19.8M919%
Total Debt47.2M694K6,801%
FUNDAMENTALS RATINGS
MNKD: Fundamental Ratings
MNKD
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
56
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MNKDUNCY
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 17 days ago
81%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
71%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NAWIX50.21N/A
N/A
Voya Global High Dividend Low Vol I
ODVIX41.43N/A
N/A
Invesco Developing Markets R6
MGLJX16.22N/A
N/A
MFS Global Real Estate R1
RSEYX12.75N/A
N/A
Columbia Global Value Inst2
KBIWX11.50N/A
N/A
KBI Global Investors Aquarius Instl

UNCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, UNCY has been loosely correlated with CERO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if UNCY jumps, then CERO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
-2.80%
CERO - UNCY
37%
Loosely correlated
+67.44%
IRD - UNCY
33%
Poorly correlated
+0.83%
UTHR - UNCY
32%
Poorly correlated
+1.69%
BBIO - UNCY
32%
Poorly correlated
-0.17%
MNKD - UNCY
30%
Poorly correlated
+1.60%
More